Methyl jasmonate seed treatment enhances Norway spruce seedling resistance to Botrytis cinerea via a multitude of defense responses

Methyl jasmonate (MeJA) is known to effectively protect Norway spruce (Picea abies) against pests and pathogens. However, MeJA application to spruce saplings can significantly reduce growth and is not feasible to use in protecting older trees due to cost. Seed treatment with MeJA or other priming stimulants with fewer negatives could be a practical solution to enhance Norway spruce resistance. Therefore, we assessed the potential of Norway spruce seed treatment with MeJA, pipecolic acid (PipA), lignan (Li), and chitosan (Chi) in enhancing the resistance of the emerged seedlings against Botrytis cinerea. For the first time, MeJA seed treatment was shown to reduce the mortality of the seedlings effectively after B. cinerea infection, with a growth reduction as a side effect. To understand the mechanisms underlying this phenomenon, we quantified phenolics, defense hormones, and differential transcript expressions. MeJA seed treatment increased the concentration of the flavan-3-ols catechin and proanthocyanidin B1. Transcriptomic data suggested an increase in oxidative stress protection, cell wall reinforcement, and pathogenesis-related protein production. Our data also suggested an antagonistic relationship in hormonal signaling between abscisic acid (ABA) and jasmonic acid (JA)/ethylene (ET). Overall, our findings indicated MeJA seed treatment enhanced resistance of young seedlings against B. cinerea via a multitude of defense responses, modulated by complex regulatory systems.